Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11228534 | 1.00 | MAPK1 (0.35) | MAPK1ALDH1A1HPGDCYP1A2KDM4C | |
| Potassium Ion SCHEMBL8056549 | 0.96 | MAPK1 (0.35) | MAPK1ALDH1A1HPGDCYP1A2KDM4C | |
| SCHEMBL10831559 | 0.81 | ALDH1A1 (0.38) | MAPK1ALDH1A1HPGDCYP1A2KDM4C | |
| SCHEMBL829258 | 0.80 | ALDH1A1 (0.47) | MAPK1ALDH1A1HPGDCYP1A2KDM4C | |
| SCHEMBL11356709 | 0.79 | CA1 (0.34) | CYP1A2 | |
| SCHEMBL8056548 | 0.78 | ALDH1A1 (0.46) | MAPK1ALDH1A1HPGDCYP1A2KDM4C | |
| SCHEMBL7764225 | 0.78 | MAPK1 (0.36) | MAPK1ALDH1A1HPGDCYP1A2KDM4C | |
| SCHEMBL7764233 | 0.78 | MAPK1 (0.36) | MAPK1ALDH1A1HPGDCYP1A2KDM4C | |
| SCHEMBL10831333 | 0.78 | MAPK1 (0.40) | MAPK1ALDH1A1HPGD | |
| SCHEMBL11363558 | 0.78 | EPHX2 (0.36) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410534-B2 | Nickel electroplating compositions for rough nickel | DUPONT ELECTRONIC MATERIALS INTERNATIONAL, LLC (US) | 2025-09-09 | — | — | US | claimed |
| US-20240117516-A1 | NICKEL ELECTROPLATING COMPOSITIONS FOR ROUGH NICKEL | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2024-04-11 | — | — | US | claimed |
| EP-4343038-A1 | NICKEL ELECTROPLATING COMPOSITIONS FOR ROUGH NICKEL | Rohm and Haas Electronic Materials LLC (US) | 2024-03-27 | — | — | EP | claimed |
| US-12410534-B2 | Nickel electroplating compositions for rough nickel | DUPONT ELECTRONIC MATERIALS INTERNATIONAL, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20240117516-A1 | NICKEL ELECTROPLATING COMPOSITIONS FOR ROUGH NICKEL | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2024-04-11 | — | — | US | disclosed |
| EP-4343038-A1 | NICKEL ELECTROPLATING COMPOSITIONS FOR ROUGH NICKEL | Rohm and Haas Electronic Materials LLC (US) | 2024-03-27 | — | — | EP | disclosed |
| EP-4299797-A2 | SILVER ELECTROPLATING COMPOSITIONS AND METHODS FOR ELECTROPLATING ROUGH MATT SILVER | Rohm and Haas Electronic Materials LLC (US) | 2024-01-03 | — | — | EP | disclosed |
| US-9988535-B2 | Thiol group-containing colored compound, metal nanowire, dispersion liquid, transparent conductive film, information input device, and electronic apparatus | DEXERIALS CORPORATION (JP) | 2018-06-05 | — | — | US | disclosed |
| US-20180082762-A1 | Transparent Conductive Film, Dispersion Liquid, Information Input Device, and Electronic Equipment | DEXERIALS CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |
| US-20180037740-A1 | PHTHALOCYANINE-BASED COMPLEX COMPOUND | DEXERIALS CORPORATION (JP) | 2018-02-08 | — | — | US | disclosed |
| US-20170069691-A1 | DISPERSION LIQUID, TRANSPARENT CONDUCTIVE FILM, INPUT DEVICE, AND ORGANIC ELECTROLUMINESCENT LIGHTING DEVICE | DEXERIALS CORPORATION (JP) | 2017-03-09 | — | — | US | disclosed |
| US-20120071489-A1 | DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-22 | — | — | US | disclosed |
| EP-2419413-A1 | DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES | Takeda Pharmaceutical Company Limited (JP) | 2012-02-22 | — | — | EP | disclosed |
| EP-0980022-B1 | Method for preparing silver halide emulsion and silver halide photographic material | KONISHIROKU PHOTO IND (JP) | 2004-05-06 | — | — | EP | disclosed |
| US-6524782-B1 | No roller mark even during rapid processing at low replenish rates; no stain due to remained sensitizing dye; reacting silver salt and a halide salt in presence of fine silver halide grains containing gallium, indium and Group 8, 9, 10 | KONICA CORPORATION (JP) | 2003-02-25 | — | — | US | disclosed |
| US-6218092-B1 | AUTOMATIC PROCESSING | KONICA CORPORATION (JP) | 2001-04-17 | — | — | US | disclosed |
| EP-0980022-A1 | Method for preparing silver halide emulsion and silver halide photographic material | KONICA CORPORATION (JP) | 2000-02-16 | — | — | EP | disclosed |
| US-5962209-A | TABULAR SILVER HALIDE GRAINS HAVING AN ASPECT RATIO OF 2 TO 15, (100) MAJOR FACES WITH AN EDGE RATIO OF 1 TO 2, AND A SILVER CHLORIDE CONTENT OF 50 MOL % OR MORE; AND SAID EMULSION LAYER FURTHER CONTAINING A LEUCO COMPOUND CAPABLE OF FORMING A | KONICA CORPORATION (JP) | 1999-10-05 | — | — | US | disclosed |
| US-5792793-A | STABLE COMPLEX COMPRISING SILVER AND A THIOL COMPOUND; NONIRRITATING TO SKIN/MUCOUS MEMBRANES AND COMPATIBLE WITH CARRIER RESINS | MEIJI MILK PRODUCTS CO., LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0727427-A1 | ANTIBACTERIAL, ANTIFUNGAL AND ANTIVIRAL AGENT | MEIJI MILK PRODUCTS COMPANY LIMITED (JP) | 1996-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071489-A1 | DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES | RBP4, RBP1, FABP4 | MAPK1 4422/4885ALDH1A1 784/4885HPGD 3972/4885 |
| US-20180037740-A1 | PHTHALOCYANINE-BASED COMPLEX COMPOUND | TCP1, MT-CO1, PBRM1 | MAPK1 1398/4885ALDH1A1 1548/4885HPGD 3298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.